166 related articles for article (PubMed ID: 19221513)
1. Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations.
Launay O; Toneatti C; Bernède C; Njamkepo E; Petitprez K; Leblond A; Larnaudie S; Goujon C; Ungeheuer MN; Ajana F; Raccurt C; Beytout J; Chidiac C; Bouhour D; Guillemot D; Guiso N
Hum Vaccin; 2009 May; 5(5):341-6. PubMed ID: 19221513
[TBL] [Abstract][Full Text] [Related]
2. [Immunity of children aged 6-8 against pertussis, tetanus and diphtheria].
Slusarczyk J; Dulny G; Nowak K; Krszyna J; Wysokińska T; Fordymacka A; Gzyl A; Janaszek W; Gniadek G
Przegl Epidemiol; 2002; 56(1):39-48. PubMed ID: 12150066
[TBL] [Abstract][Full Text] [Related]
3. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of antibodies to diphtheria, tetanus and pertussis among healthy adolescents and adults in Iran.
Pourakbari B; Moradi B; Mirzaee F; Mahmoudi S; Teymuri M; Mamishi S
Roum Arch Microbiol Immunol; 2013; 72(4):250-4. PubMed ID: 24923108
[TBL] [Abstract][Full Text] [Related]
5. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.
Plosker GL
BioDrugs; 2009; 23(4):253-67. PubMed ID: 19697967
[TBL] [Abstract][Full Text] [Related]
6. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
[TBL] [Abstract][Full Text] [Related]
7. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
8. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
9. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization.
Frampton JE; Keating GM
BioDrugs; 2006; 20(6):371-89. PubMed ID: 17176125
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
Dominicus R; Galtier F; Richard P; Baudin M
Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
[TBL] [Abstract][Full Text] [Related]
11. Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.
Vandermeulen C; Theeten H; Rathi N; Kuriyakose S; Han HH; Sokal E; Hoppenbrouwers K; Van Damme P
Vaccine; 2015 Jun; 33(26):3026-34. PubMed ID: 25613716
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials.
Van Damme P; McIntyre P; Grimprel E; Kuriyakose S; Jacquet JM; Hardt K; Messier M; Van Der Meeren O
Vaccine; 2011 Aug; 29(35):5932-9. PubMed ID: 21718738
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
14. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
Kovac M; Rathi N; Kuriyakose S; Hardt K; Schwarz TF
Vaccine; 2015 May; 33(22):2594-601. PubMed ID: 25882172
[TBL] [Abstract][Full Text] [Related]
16. [Antibody levels for diphtheria, tetanus and pertussis in young adult females immunized with whole cell pertussis-diphtheria-tetanus toxoid vaccine in infancy].
Meno Y; Okada K; Yamaguchi Y; Morokuma K; Okuma K; Ueda K
Kansenshogaku Zasshi; 2000 Feb; 74(2):150-4. PubMed ID: 10741006
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
[TBL] [Abstract][Full Text] [Related]
18. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries.
Berbers G; van Gageldonk P; Kassteele JV; Wiedermann U; Desombere I; Dalby T; Toubiana J; Tsiodras S; Ferencz IP; Mullan K; Griskevicius A; Kolupajeva T; Vestrheim DF; Palminha P; Popovici O; Wehlin L; Kastrin T; Maďarová L; Campbell H; Ködmön C; Bacci S; Barkoff AM; He Q;
Nat Commun; 2021 May; 12(1):2871. PubMed ID: 34001895
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH; Tan PT; Han HH; Bock HL
Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
[TBL] [Abstract][Full Text] [Related]
20. [New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria].
Siegrist CA
Rev Med Suisse; 2012 Jan; 8(324):125-8. PubMed ID: 23185823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
